Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth

Cancer Cell

Volumn 6, Issue 6, 2004, Pages 597-609

  Fei, Peiwen ^a   Wang, Wenge ^a   Kim, Seok Hyun ^a   Wang, Shulin ^a   Burns, Timothy F ^a   Sax, Joanna K ^a   Buzzai, Monica ^a   Dicker, David T ^a   McKenna, W Gillies ^a   Bernhard, Eric J ^a   El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; PROTEIN BNIP3L; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TUMOR GROWTH; UPREGULATION; WILD TYPE;

ANIMALIA;

EID: 19944371176     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.10.012     Document Type: Article

References (61)

1. Achison M., Hupp T.R. Hypoxia attenuates the p53 response to cellular damage. Oncogene. 22:2003;3431-3440
2. An W.G., Kanekal M., Simon M.C., Maltepe E., Blagosklonny M.V., Neckers L.M. Stabilization of wild-type p53 by hypoxia-inducible factor 1α Nature. 392:1998;405-408
3. Anderson L.M., Krotz S., Weitzman S.A., Thimmapaya B. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach. Cancer Gene Ther. 7:2000;845-852
4. Arany Z., Huang L.E., Eckner R., Bhattacharya S., Jiang C., Goldberg M.A., Bunn H.F., Livingston D.M. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. USA. 93:1996;12969-12973
5. Attardi L.D., Jacks T. The role of p53 in tumour suppression. lessons from mouse models Cell. Mol. Life Sci. 55:1999;48-63
6. Aurelio O.N., Kong X.T., Gupta S., Stanbridge E.J. p53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines. Mol. Cell. Biol. 20:2000;770-778
7. Bahnson A.B., Dunigan J.T., Baysal B.E., Mohney T., Atchison R.W., Nimgaonkar M.T., Ball E.D., Barranger J.A. Centrifugal enhancement of retroviral mediated gene transfer. J. Virol. Methods. 54:1995;131-143
8. Bardeesy N., Beckwith J.B., Pelletier J. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res. 55:1995;215-219
9. Bruick R.K. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc. Natl. Acad. Sci. USA. 97:2000;9082-9087
10. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553
11. Bunnell B.A., Muul L.M., Donahue R.E., Blaese R.M., Morgan R.A. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA. 92:1995;7739-7743
12. Burns T.F., El-Deiry W.S. Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J. Biol. Chem. 276:2001;37879-37886
13. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:1998;485-490
14. Chan T.A., Hwang P.M., Hermeking H., Kinzler K.W., Vogelstein B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev. 14:2000;1584-1588
15. De Angelis P.M., Fjell B., Kravik K.L., Huag T., Tunheim S.H., Reichelt W., Beigi M., Clausen O.P., Galteland E., Stokke T. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. Int. J. Oncol. 24:2004;1279-1288
16. Denko N.C., Fontana L.A., Hudson K.M., Sutphin P.D., Raychaudhuri S., Altman R., Giaccia A.J. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene. 22:2003;5907-5914
17. Eischen C.M., Roussel M.F., Korsmeyer S.J., Cleveland J.L. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol. Cell. Biol. 21:2001;7653-7662
18. El-Deiry W.S. Regulation of p53 downstream genes. Semin. Cancer Biol. 8:1998;345-357
19. El-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet. 1:1992;45-49
20. Erler J.T., Cawthorne C.J., Williams K.J., Koritzinsky M., Wouters B.G., Wilson C., Miller C., Demonacos C., Stratford I.J., Dive C. Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol. Cell. Biol. 24:2004;2875-2889
21. Fei P., El-Deiry W.S. P53 and radiation responses. Oncogene. 22:2003;5774-5783
22. Fei P., Bernhard E.J., El-Deiry W.S. Tissue-specific induction of p53 targets in vivo. Cancer Res. 62:2002;7316-7327
23. Graeber T.G., Peterson J.F., Tsai M., Monica K., Fornace A.J. Jr., Giaccia A.J. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:1994;6264-6277
24. Graeber T.G., Osmanian C., Jacks T., Housman D.E., Koch C.J., Lowe S.W., Giaccia A.J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 379:1996;88-91
25. Hammond E.M., Denko N.C., Dorie M.J., Abraham R.T., Giaccia A.J. Hypoxia links ATR and p53 through replication arrest. Mol. Cell. Biol. 22:2002;1834-1843
26. Hansson L.O., Friedler A., Freund S., Rudiger S., Fersht A.R. Two sequence motifs from HIF-1α bind to the DNA-binding site of p53. Proc. Natl. Acad. Sci. USA. 99:2002;10305-10309
27. Jeffers J.R., Parganas E., Lee Y., Yang C., Wang L., Brennan J., Maclean K.H., Han J., Chittenden T., Ihle J., et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell. 4:2003;321-328
28. Kaeser M.D., Iggo R.D. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl. Acad. Sci. USA. 99:2002;95-100
29. Kim J.Y., Ahn H.J., Ryu J.H., Suk K., Park J.H. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1-α J. Exp. Med. 199:2004;113-124
30. Koumenis C., Alarcon R., Hammond E., Sutphin P., Hoffman W., Murphy M., Derr J., Taya Y., Lowe S.W., Kastan M., Giaccia A. Regulation of p53 by hypoxia. dissociation of transcriptional repression and apoptosis from p53-dependent transactivation Mol. Cell. Biol. 21:2001;1297-1310
31. Kubasiak L.A., Hernandez O.M., Bishopric N.H., Webster K.A. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc. Natl. Acad. Sci. USA. 99:2002;12825-12830
32. Lai J., Flanagan J., Phillips W.A., Chenevix-Trench G., Arnold J. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer. Br. J. Cancer. 88:2003;270-276
33. Lane D.P. p53, guardian of the genome. Nature. 358:1992;15-16
34. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331
35. Marchetti P., Cannita K., Ricevuto E., De Galitiis F., Di Rocco Z.C., Tessitore A., Bisegna R., Porzio G., De Rubeis G.P., Ventura T., et al. Prognostic value of p53 molecular status in high-risk primary breast cancer. Ann. Oncol. 14:2003;704-708
36. Meijerink J.P., Mensink E.J., Wang K., Sedlak T.W., Sloetjes A.W., de Witte T., Waksman G., Korsmeyer S.J. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood. 91:1998;2991-2997
37. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 7:2001;683-694
38. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:2000;1053-1058. a
39. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nishimori H., Tamai K., Tokino T., Nakamura Y., Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell. 102:2000;849-862. b
40. Okami J., Simeone D.M., Logsdon C.D. Silencing of the hypoxia-inducible protein Bnip3 in pancreatic cancer. Cancer Res. 64:2004;5338-5346
41. Pan Y., Oprysko P.R., Arsham A.M., Koch C.J., Simon M.C. p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment. Oncogene. 23:2004;4975-4983
42. Piret J.P., Mottet D., Raes M., Michiels C. Is HIF-1α a pro- or an anti-apoptotic protein? Biochem. Pharmacol. 64:2002;889-892
43. Sax J.K., Fei P., Murphy M.E., Bernhard E., Korsmeyer S.J., El-Deiry W.S. BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol. 4:2002;842-849
44. Schmaltz C., Hardenbergh P.H., Wells A., Fisher D.E. Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell. Biol. 18:1998;2845-2854
45. Schmitt C.A., Fridman J.S., Yang M., Baranov E., Hoffman R.M., Lowe S.W. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell. 1:2002;289-298
46. Semenza G.L. HIF-1 and human disease. one highly involved factor Genes Dev. 14:2000;1983-1991
47. Shimizu S., Eguchi Y., Kamiike W., Itoh Y., Hasegawa J., Yamabe K., Otsuki Y., Matsuda H., Tsujimoto Y. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res. 56:1996;2161-2166
48. Soengas M.S., Capodieci P., Polsky D., Mora J., Esteller M., Opitz-Araya X., McCombie R., Herman J.G., Gerald W.L., Lazebnik Y.A., et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 409:2001;207-211
49. Sowter H.M., Ratcliffe P.J., Watson P., Greenberg A.H., Harris A.L. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61:2001;6669-6673
50. Sun, J.L., He, X.S., Yu, Y.H., and Chen, Z.C. (2004). [Expression and structure of BNIP3L in lung cancer]. Ai Zheng 23, 8-14.
51. Symonds H., Krall L., Remington L., Saenz-Robles M., Lowe S., Jacks T., Van Dyke T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell. 78:1994;703-711
52. Tokino T., Thiagalingam S., El-Deiry W.S., Waldman T., Kinzler K.W., Vogelstein B. p53 tagged sites from human genomic DNA. Hum. Mol. Genet. 3:1994;1537-1542
53. 2 tension measurements Cancer Res. 51:1991;3316-3322
54. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., Adams J.M., Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science. 302:2003;1036-1038
55. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310
56. Wang W., El-Deiry W.S. Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model. Cancer Biol. Ther. 2:2003;196-202
57. Wang S., El-Deiry W.S. Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil. Cancer Res. 64:2004;6666-6672
58. Weinmann M., Welz S., Bamberg M. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology. Curr. Med. Chem. Anti-Canc. Agents. 3:2003;364-374
59. Wenger R.H., Camenisch G., Desbaillets I., Chilov D., Gassmann M. Up-regulation of hypoxia-inducible factor-1α is not sufficient for hypoxic/anoxic p53 induction. Cancer Res. 58:1998;5678-5680
60. Yasuda M., Han J.W., Dionne C.A., Boyd J.M., Chinnadurai G. BNIP3α a human homolog of mitochondrial proapoptotic protein BNIP3 Cancer Res. 59:1999;533-537
61. Yussman M.G., Toyokawa T., Odley A., Lynch R.A., Wu G., Colbert M.C., Aronow B.J., Lorenz J.N., Dorn G.W. II Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat. Med. 8:2002;725-730